Key facts
- This page summarizes John M. Evans's Form 4 filing for Beam Therapeutics Inc. (BEAM).
- 9 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 29 Jul 2022, 16:06.
John M. Evans - 28 Jul 2022 Form 4 Insider Report for Beam Therapeutics Inc. (BEAM)
- Reporting relationship
- CEO, Director
- Issuer ticker
- BEAM
- Reported as of
- 28 Jul 2022
- Net transaction value
- -$3,288,081
- SEC form
- 4
- Accepted by SEC
- 29 Jul 2022, 16:06:01 UTC
- Prior SEC filing
- 13 Jun 2022
- Next SEC filing
- 02 Nov 2022
- Source filing
- View source filing
- Reporting owner signature
- By: /s/ Christine Bellon, Attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
John M. Evans filed Form 4 for Beam Therapeutics Inc. (BEAM) on 29 Jul 2022.
Change
- Previous filing in this sequence was filed on 13 Jun 2022.
- Current net transaction value: -$3,288,081.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
BEAM
transaction
Common Stock
Sale
- Transaction value
- $660,429
- Shares
- -10,181
- Change %
- -0.91%
- Price
- $64.87
- Shares after
- 1,108,339
- Date
- 28 Jul 2022
- Ownership
- Direct
- Footnotes
- F1, F2
BEAM
transaction
Common Stock
Sale
- Transaction value
- $1,002,896
- Shares
- -15,236
- Change %
- -1.4%
- Price
- $65.82
- Shares after
- 1,093,103
- Date
- 28 Jul 2022
- Ownership
- Direct
- Footnotes
- F1, F3
BEAM
transaction
Common Stock
Sale
- Transaction value
- $104,255
- Shares
- -1,562
- Change %
- -0.14%
- Price
- $66.74
- Shares after
- 1,091,541
- Date
- 28 Jul 2022
- Ownership
- Direct
- Footnotes
- F1, F4
BEAM
transaction
Common Stock
Sale
- Transaction value
- $193,093
- Shares
- -2,848
- Change %
- -0.26%
- Price
- $67.80
- Shares after
- 1,088,693
- Date
- 28 Jul 2022
- Ownership
- Direct
- Footnotes
- F1, F5
BEAM
transaction
Common Stock
Sale
- Transaction value
- $11,849
- Shares
- -173
- Change %
- -0.02%
- Price
- $68.49
- Shares after
- 1,088,520
- Date
- 28 Jul 2022
- Ownership
- Direct
- Footnotes
- F1
BEAM
transaction
Common Stock
Sale
- Transaction value
- $451,113
- Shares
- -6,953
- Change %
- -4.9%
- Price
- $64.88
- Shares after
- 136,047
- Date
- 28 Jul 2022
- Ownership
- By John M. Evans, III 2018 Irrevocable Trust
- Footnotes
- F1, F6
BEAM
transaction
Common Stock
Sale
- Transaction value
- $698,673
- Shares
- -10,599
- Change %
- -7.8%
- Price
- $65.92
- Shares after
- 125,448
- Date
- 28 Jul 2022
- Ownership
- By John M. Evans, III 2018 Irrevocable Trust
- Footnotes
- F1, F7
BEAM
transaction
Common Stock
Sale
- Transaction value
- $13,389
- Shares
- -201
- Change %
- -0.16%
- Price
- $66.61
- Shares after
- 125,247
- Date
- 28 Jul 2022
- Ownership
- By John M. Evans, III 2018 Irrevocable Trust
- Footnotes
- F1, F8
BEAM
transaction
Common Stock
Sale
- Transaction value
- $152,383
- Shares
- -2,247
- Change %
- -1.8%
- Price
- $67.82
- Shares after
- 123,000
- Date
- 28 Jul 2022
- Ownership
- By John M. Evans, III 2018 Irrevocable Trust
- Footnotes
- F1, F9
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 9 footnotes
Footnote F1
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. The sale price reported is a weighted average price. The Reporting Person undertakes to provide to Beam Therapeutics Inc. ("BEAM"), any security holder of BEAM or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Footnote F2
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $64.43 to $65.42, inclusive.
Footnote F3
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $65.43 to $66.34, inclusive.
Footnote F4
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $66.44 to $67.37, inclusive.
Footnote F5
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $67.45 to $67.87, inclusive.
Footnote F6
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $64.43 to $65.38, inclusive.
Footnote F7
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $65.46 to $66.45, inclusive.
Footnote F8
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $66.50 to $66.61, inclusive.
Footnote F9
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $67.72 to $68.49, inclusive.